The gut microbiome, mild cognitive impairment, and probiotics: A randomized clinical trial in middle-aged and older adults

Coming Soon.

Year: 2022

Reference: Aljumaah, M. R., Bhatia, U., Roach, J., Gunstad, J., & Azcarate Peril, M. A. (2022). The gut microbiome, mild cognitive impairment, and probiotics: A randomized clinical trial in middle-aged and older adults. Clinical nutrition (Edinburgh, Scotland), 41(11), 2565–2576. https://doi.org/10.1016/j.clnu.2022.09.012

Related Studies

The gut microbiota-immune-brain axis: Therapeutic implications

Role of the Microbiota-Gut-Brain Axis in Human Health Human health is greatly impacted by the microbiota-gut-brain axis, which affects behavior, brain activity, and gastrointestinal function. A key communication pathway within this axis is the immune system, which connects the gut microbiome to neuroinflammatory processes in both health and disease. Findings from Recent Review on Gut-Brain-Immune […]

The role of the gut microbiota in the development and progression of major depressive and bipolar disorder

This 2021 article provides a review of human studies analyzing the relationship between the gut microbiota and major bipolar/depressive disorder. The reviewers found that depressed patients tended to show lower microbial diversity in their gut. This review also describes the positive effect of probiotics containing Bifidobacterium and/or Lactobacillus spp. on depressive symptoms. In addition, new […]